Associated Papers
Multicenter study of patients with transthyretin cardiac amyloidosis in Poland: Clinical characteristics, genotyping, electrocardiographic features, outcome predictors, and tafamidis treatment outcomes.
Gawor-Prokopczyk M et al.
Kardiologia Polska, 2026
Effectiveness and Utility of Genetic Testing in Establishing a Diagnosis of Hereditary Transthyretin Amyloidosis.
Singh A et al.
Journal of Clinical Medicine, 2025
Integrative structural profiling and ligand optimisation across the transthyretin mutational landscape.
Lomoio U et al.
Npj Systems Biology and Applications, 2025
Pre-symptomatic scintigraphic and genetic cascade screening in cardiac transthyretin amyloidosis.
Holcman K et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2025
Transthyretin-related amyloid cardiomyopathy: A single-center experience in southern Poland, an endemic area.
Holcman K et al.
Kardiologia Polska, 2025
Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program.
Bhatt K et al.
Journal of the American Heart Association, 2024
Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy.
Garcia-Pavia P et al.
Esc Heart Failure, 2024
Rare transthyretin gene variants (p.Ala45Thr, p.Val91Ala, p.Phe53Cys, p.Ala101Val, p.Glu109Lys, and p.Phe53Leu): diagnostic pitfalls and clinical characteristics of Polish patients with transthyretin cardiac amyloidosis.
Gawor-Prokopczyk M et al.
Polish Archives of Internal Medicine, 2024
Diflunisal versus tafamidis on neuropathy and cardiomyopathy in hereditary transthyretin amyloidosis.
Chao CC et al.
Annals of Clinical and Translational Neurology, 2024
Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness.
Holcman K et al.
The International Journal of Cardiovascular Imaging, 2024
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey.
González-Moreno J et al.
Cardiology and Therapy, 2024
Multimodality family screening of patients with cardiac transthyretin amyloidosis: a case of an asymptomatic patient.
Mróz K et al.
European Heart Journal. Case Reports, 2023
Three Newly Recognized Likely Pathogenic Gene Variants Associated with Hereditary Transthyretin Amyloidosis.
Patel JK et al.
Neurology and Therapy, 2022
Cardiomyopathy correlates to nerve damage in p.A117S late-onset transthyretin amyloid polyneuropathy.
Lin YH et al.
Annals of Clinical and Translational Neurology, 2022
Amyloidogenicity assessment of transthyretin gene variants.
Grether NB et al.
Annals of Clinical and Translational Neurology, 2022
Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis.
Gawor M et al.
Cardiology Journal, 2022
Early Detection of Cardiac Amyloidosis in Transthyretin Mutation Carriers.
Nagano N et al.
International Heart Journal, 2022
Management of transthyretin amyloidosis.
Condoluci A et al.
Swiss Medical Weekly, 2021
Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records.
Carry BJ et al.
Jacc. Cardiooncology, 2021
Early changes of nerve integrity in preclinical carriers of hereditary transthyretin Ala117Ser amyloidosis with polyneuropathy.
Chiang MC et al.
European Journal of Neurology, 2021
TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients.
Moshe-Lilie O et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis, 2020
Hereditary transthyretin amyloidosis caused by the rare Phe33Leu mutation.
Björkenheim A et al.
Bmj Case Reports, 2020
Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
Lipowska M et al.
Neurologia I Neurochirurgia Polska, 2020
A molecular mechanism for transthyretin amyloidogenesis.
Yee AW et al.
Nature Communications, 2019
Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience.
Rowczenio D et al.
Human Mutation, 2019
Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis.
Iorio A et al.
Bmc Genomics, 2017